Departement
Klinische Forschung
Achtung: Diese Seite kann nur von Administratoren besucht werden, da Sie nicht freigeschalten wurde.
Zurück
Publications Pfister Marc

Pharmacokinetics and tolerability of intranasal or intravenous administration of nalbuphine in infants.

Pfiffner M; Gotta V; Pfister M; Vonbach P; Berger-Olah E. Archives of Disease in Childhood. 2023.

Characterization of the Population Pharmacokinetics of Moxidectin in Adults Infected with Strongyloides Stercoralis: Support for a Fixed-Dose Treatment Regimen.

Smit C; Hofmann D; Sayasone S; Keiser J; Pfister M. Clinical Pharmacokinetics. 2022.

Dosing strategies of imipenem in neonates based on pharmacometric modelling and simulation.

Dao K; Fuchs A; André P; Giannoni E; Decosterd LA; Marchetti O; Asner SA; Pfister M; Widmer N; Buclin T; Csajka C; Guidi M. Journal of Antimicrobial Chemotherapy. 2022.

Dyskalemia risk associated with fixed-dose anti-hypertensive medication combinations

Qin L; Zhang N; Ishigami J; Miller ER 3rd; Pfister M; Moran AE; Cox E. . 2022.

Evaluation of machine learning methods for covariate data imputation in pharmacometrics.

Bräm DS; Nahum U; Atkinson A; Koch G; Pfister M. CPT: pharmacometrics & systems pharmacology. 2022.

Infliximab Treatment Does Not Lead to Full TNF-α Inhibition: A Target-Mediated Drug Disposition Model.

Ternant D; Pfister M; Le Tilly O; Mulleman D; Picon L; Willot S; Passot C; Bejan-Angoulvant T; Lecomte T; Paintaud G; Koch G. Clinical Pharmacokinetics. 2022.

Leveraging Predictive Pharmacometrics-Based Algorithms to Enhance Perinatal Care-Application to Neonatal Jaundice.

Koch G; Wilbaux M; Kasser S; Schumacher K; Steffens B; Wellmann S; Pfister M. Frontiers in Pharmacology. 2022.

Machine learning-based algorithm as an innovative approach for the differentiation between diabetes insipidus and primary polydipsia in clinical practice.

Nahum U; Refardt J; Chifu I; Fenske WK; Fassnacht M; Szinnai G; Christ-Crain M; Pfister M. European journal of endocrinology. 2022.

Novel strategy to personalise use of ibuprofen for closure of patent ductus arteriosus in preterm neonates.

Samiee-Zafarghandy S; van Donge T; Fusch G; Pfister M; Jacob G; Atkinson A; Rieder MJ; Smit C; Van Den Anker J. Archives of Disease in Childhood. 2022.

Optimizing moxidectin dosing for Strongyloides stercoralis infections: Insights from pharmacometric modeling.

Hofmann D; Smit C; Sayasone S; Pfister M; Keiser J. Clinical and Translational Science. 2022.

Pharmacokinetic modelling and simulation to optimize albendazole dosing in hookworm- or Trichuris trichiura-infected infants to adults.

Hofmann D; Brussee JM; Schulz JD; Coulibaly JT; Pfister M; Keiser J. Journal of Antimicrobial Chemotherapy. 2022.

Pharmacometric Analysis of Intranasal and Intravenous Nalbuphine to Optimize Pain Management in Infants.

Pfiffner M; Berger-Olah E; Vonbach P; Pfister M; Gotta V. Frontiers in Pediatrics. 2022.

Semi- Mechanistic Modeling of Copeptin and Aldosterone Kinetics and Dynamics in Response to Rehydration Treatment for Diabetic Ketoacidosis in Children

Otto M; Burckhardt MA; Szinnai G; Pfister M; Gotta V. . 2022.

Steering Away from Current Amoxicillin Dose Reductions in Hospitalized Patients with Impaired Kidney Function to Avoid Subtherapeutic Drug Exposure

Smit C.; Sen S.; von Dach E.; Karmime A.; Lescuyer P.; Tonoli D.; Bielicki J.; Huttner A.; Pfister M.. Antibiotics (Basel, Switzerland). 2022.

Tapering of biological treatment in autoinflammatory diseases: a scoping review.

Welzel T; Oefelein L; Twilt M; Pfister M; Kuemmerle-Deschner JB; Benseler SM. Pediatric rheumatology online journal. 2022.

Therapeutic Drug Monitoring of Orally Administered Letermovir Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Royston L.; Masouridi-Levrat S.; Gotta V.; Royston E.; Pressacco-Brossier C.; Aad Y.A.; Tonoli D.; Karmime A.; Jayo M.; Van Delden C.; Lescuyer P.; Pfister M.; Chalandon Y.; Neofytos D.. Antimicrobial Agents and Chemotherapy. 2022.

Understanding efficacy-safety balance of biologics in moderate-to-severe pediatric psoriasis.

Golhen K; Winskill C; Theiler M; Buettcher M; Yeh YH; Zhang N; Welzel T; Pfister M. Frontiers in Medicine. 2022.

Vaginale Geburt und niedriges Gestationsalter sind Hauptrisikofaktoren für Hypernatriämie bei Frühgeborenen < 32 SSW.

Eugster NS; Corminboeuf F; Koch G; Vogt JE; Sutter T; van Donge T; Pfister M; Gerull R. Klinische Padiatrie. 2022.

Value of Literature Review to Inform Development and Use of Biologics in Juvenile Idiopathic Arthritis.

Golhen K; Winskill C; Yeh C; Zhang N; Welzel T; Pfister M. . 2022.

Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology - what we know and what we do not know from randomized controlled trials.

Welzel T; Winskill C; Zhang N; Woerner A; Pfister M. Pediatric rheumatology online journal. 2021.

Characterizing dynamics of serum creatinine and creatinine clearance in extremely low birth weight neonates during the first 6 weeks of life.

van Donge T; Allegaert K; Gotta V; Smits A; Levtchenko E; Mekahli D; van den Anker J; Pfister M. Pediatric Nephrology. 2021.

Characterizing Effects of Antidiabetic Drugs on Heart Rate, Systolic and Diastolic Blood Pressure.

Maringwa J; Sardu ML; Hang Y; Czerniak R; Vishnubhotla M; Vakilynejad M; Pfister M. Clinical Pharmacology and Therapeutics. 2021.

Correction to: Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology - what we know and what we do not know from randomized controlled trials.

Welzel T; Winskill C; Zhang N; Woerner A; Pfister M. . 2021.

Corrigendum to: Age appropriate reference intervals for eight kidney function and injury markers in infants, children and adolescents.

van Donge T; Staub E; Atkinson A; Gotta V; van den Anker J; Risch L; Welzel T; Pfister M. . 2021.

Creatinine trends to detect ibuprofen-related maturational adverse drug events in neonatal life: a simulation study for the ELBW newborn Creatinine trends during ibuprofen exposure in ELBW newborns

Tamara Van Donge,; Karel Allegaert; Marc Pfister; Anne Smits; Johannes Nicolaas Van Den Anker. . 2021.

Hemodialysis (HD) dose and ultrafiltration rate are associated with survival in pediatric and adolescent patients on chronic HD-a large observational study with follow-up to young adult age.

Gotta V; Marsenic O; Atkinson A; Pfister M. Pediatric Nephrology. 2021.

High Acceptability of an Orally Dispersible Tablet Formulation by Children.

Wagner-Hattler L; Kiene K; Bielicki J; Pfister M; Puchkov M; Huwyler J. Children. 2021.

Identifying key predictors of mortality in young patients on chronic haemodialysis-a machine learning approach.

Gotta V; Tancev G; Marsenic O; Vogt JE; Pfister M. Nephrology Dialysis Transplantation. 2021.

Modeling of levothyroxine in newborns and infants with congenital hypothyroidism: challenges and opportunities of a rare disease multi-center study.

Koch G; Steffens B; Leroux S; Gotta V; Schropp J; Gächter P; Bachmann F; Welzel T; Janner M; L'Allemand D; Konrad D; Szinnai G; Pfister M. Journal of Pharmacokinetics and Pharmacodynamics. 2021.

OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control.

Bachmann F; Koch G; Pfister M; Szinnai G; Schropp J. Journal of optimization theory and applications. 2021.

Pharmacometric analyses to characterize the effect of CSL112 on apolipoprotein A-I and cholesterol efflux capacity in acute myocardial infarction patients.

Zheng B; Duffy D; Tricoci P; Kastrissios H; Pfister M; Wright SD; Gille A; Tortorici MA. British Journal of Clinical Pharmacology. 2021.

Pharmacometric analysis linking immunoglobulin exposure to clinical efficacy outcomes in chronic inflammatory demyelinating polyneuropathy.

Tortorici MA; Yuraszeck T; Cornblath D; Bril V; Hartung HP; Sobue G; Lewis RA; Merkies ISJ; Lawo JP; Praus M; Durn BL; Mielke O; Ma X; Jauslin P; Pfister M; van Schaik IN; PATH study group. CPT: pharmacometrics & systems pharmacology. 2021.

Pharmacometric Analysis of Tribendimidine Monotherapy and Combination Therapies To Achieve High Cure Rates in Patients with Hookworm Infections.

Brussee JM; Neodo A; Schulz JD; Coulibaly JT; Pfister M; Keiser J. Antimicrobial Agents and Chemotherapy. 2021.

Population Pharmacokinetics and Exposure-Response Analysis of Tribendimidine To Improve Treatment for Children with Hookworm Infection.

Brussee JM; Hiroshige N; Neodo A; Coulibaly JT; Pfister M; Keiser J. Antimicrobial Agents and Chemotherapy. 2021.

Serum Creatinine and Serum Cystatin C are Both Relevant Renal Markers to Estimate Vancomycin Clearance in Critically Ill Neonates.

Leroux S; Biran V; van den Anker J; Gotta V; Zhao W; Zhang D; Jacqz-Aigrain E; Pfister M. Frontiers in Pharmacology. 2021.

The rhythm of a preterm neonate's life: ultradian oscillations of heart rate, body temperature and sleep cycles.

Koch G; Jost K; Schulzke SM; Koch R; Pfister M; Datta AN. Journal of Pharmacokinetics and Pharmacodynamics. 2021.

Age appropriate reference intervals for eight kidney function and injury markers in infants, children and adolescents.

van Donge T; Staub E; Atkinson A; Gotta V; van den Anker J; Risch L; Welzel T; Pfister M. Clinical Chemistry and Laboratory Medicine. 2020.

Amoxicillin Dosing Regimens for the Treatment of Neonatal Sepsis: Balancing Efficacy and Neurotoxicity.

van Donge T; Fuchs A; Leroux S; Pfister M; Rodieux F; Atkinson A; Giannoni E; van den Anker J; Bielicki J. Neonatology. 2020.

Artificial Intelligence and Machine Learning Applied at the Point of Care.

Angehrn Z; Haldna L; Zandvliet AS; Gil Berglund E; Zeeuw J; Amzal B; Cheung SYA; Polasek TM; Pfister M; Kerbusch T; Heckman NM. Frontiers in Pharmacology. 2020.

Caffeine preserves quiet sleep in preterm neonates.

Koch G; Schönfeld N; Jost K; Atkinson A; Schulzke SM; Pfister M; Datta AN. Pharmacology Research & Perspectives. 2020.

Clinical Pharmacology and Pharmacometrics to Better Understand Physiological Changes During Pregnancy and Neonatal Life.

van Donge T; Evers K; Koch G; van den Anker J; Pfister M. Handbook of Experimental Pharmacology. 2020.

Comparison of Blood Pressure and Kidney Markers between Adolescent Former Preterm Infants and Term Controls.

Staub E; Urfer-Maurer N; Lemola S; Risch L; Evers KS; Welzel T; Pfister M. Children. 2020.

Copeptin Kinetics and Its Relationship to Osmolality During Rehydration for Diabetic Ketoacidosis in Children.

Burckhardt MA; Gotta V; Beglinger S; Renggli L; Bachmann S; Hess M; Rentsch K; Pfister M; Koch G; Davis EA; Zumsteg U; Jones TW; Szinnai G. Journal of Clinical Endocrinology and Metabolism. 2020.

Creatinine Trends to Detect Ibuprofen-Related Maturational Adverse Drug Events in Neonatal Life: A Simulation Study for the ELBW Newborn.

van Donge T; Allegaert K; Pfister M; Smits A; van den Anker J. Frontiers in Pharmacology. 2020.

Integration of Placental Transfer in a Fetal-Maternal Physiologically Based Pharmacokinetic Model to Characterize Acetaminophen Exposure and Metabolic Clearance in the Fetus.

Mian P; Allegaert K; Conings S; Annaert P; Tibboel D; Pfister M; van Calsteren K; van den Anker JN; Dallmann A. Clinical Pharmacokinetics. 2020.

Intensive Hemodiafiltration Successfully Removes Ganciclovir Overdose and Largely Exceeds Reported Elimination During Hemodialysis-A Case Report and Review of the Literature.

Gotta V; Leuppi-Taegtmeyer A; Gessler M; Pfister M; Müller D; Jehle AW. Frontiers in Pharmacology. 2020.

Optimisation of vancomycin exposure in neonates based on the best level of evidence.

Dao K; Guidi M; André P; Giannoni E; Basterrechea S; Zhao W; Fuchs A; Pfister M; Buclin T; Csajka C. Pharmacological research. 2020.

Pharmacometric modeling to explore 4F-PCC dosing strategies for VKA reversal in patients with INR below 2.

Sarode R; Fukutake K; Yasaka M; Tortorici MA; Mangione A; Pfister M; Cuker A. Blood Advances. 2020.

Pharmacometrics and Machine Learning Partner to Advance Clinical Data Analysis.

Koch G; Pfister M; Daunhawer I; Wilbaux M; Wellmann S; Vogt JE. Clinical Pharmacology and Therapeutics. 2020.

Physiologically Based Pharmacokinetic Modeling to Characterize Acetaminophen Pharmacokinetics and N-Acetyl-p-Benzoquinone Imine (NAPQI) Formation in Non-Pregnant and Pregnant Women.

Mian P; van den Anker JN; van Calsteren K; Annaert P; Tibboel D; Pfister M; Allegaert K; Dallmann A. Clinical Pharmacokinetics. 2020.

Understanding the Effects of Kidney Disease and Dialysis Treatment on Pharmacotherapy in Children.

Gotta V; Marsenic O; Pfister M. Handbook of Experimental Pharmacology. 2020.

Understanding Urea Kinetic Factors That Enhance Personalized Hemodialysis Prescription in Children.

Gotta V; Marsenic O; Pfister M. ASAIO Journal. 2020.

Age-Dependent Changes of Kidney Injury Biomarkers in Pediatrics.

van Donge T; Welzel T; Atkinson A; van den Anker J; Pfister M. Journal of Clinical Pharmacology. 2019.

Characterization of Maternal and Neonatal Pharmacokinetic Behavior of Ceftazidime.

Dallmann A; van den Anker J; Pfister M; Koch G. Journal of Clinical Pharmacology. 2019.

Copeptin kinetics and its relationship to osmolality during rehydration for diabetic ketoacidosis in children: an observational study

Burckhardt, Marie-Anne; Beglinger, Svetlana; Gotta, Verena; Renggli, Luzia; Bachmann, Sara; Hess, Melanie; Rentsch, Katharina; Koch, Gilbert; Zumsteg, Urs; Jones, Timothy; Pfister, Marc; Szinnai, Gabor. Hormone research in paediatrics. 2019.

Dose evaluation of intravenous metamizole (dipyrone) in infants and children: a prospective population pharmacokinetic study.

Ziesenitz VC; Rodieux F; Atkinson A; Borter C; Bielicki JA; Haschke M; Duthaler U; Bachmann F; Erb TO; Gürtler N; Holland-Cunz S; van den Anker JN; Gotta V; Pfister M. European Journal of Clinical Pharmacology. 2019.

Enhanced early prediction of clinically relevant neonatal hyperbilirubinemia with machine learning.

Daunhawer I; Kasser S; Koch G; Sieber L; Cakal H; Tütsch J; Pfister M; Wellmann S; Vogt JE. Pediatric Research. 2019.

Ivermectin Dosing Strategy to Achieve Equivalent Exposure Coverage in Children and Adults

Brussee, Janneke M; Schulz, Jessica D; Coulibaly, Jean T; Keiser, Jennifer; Pfister, Marc. Clinical Pharmacology and Therapeutics. 2019.

Maturational changes in vancomycin protein binding affect vancomycin dosing in neonates.

Leroux S; van den Anker JN; Smits A; Pfister M; Allegaert K. British Journal of Clinical Pharmacology. 2019.

Methadone dosing strategies in preterm neonates can be simplified.

van Donge T; Samiee-Zafarghandy S; Pfister M; Koch G; Kalani M; Bordbar A; van den Anker J. British Journal of Clinical Pharmacology. 2019.

Personalized weight change prediction in the first week of life.

Wilbaux M; Kasser S; Gromann J; Mancino I; Coscia T; Lapaire O; van den Anker JN; Pfister M; Wellmann S. Clinical nutrition (Edinburgh, Scotland). 2019.

PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING TO CHARACTERIZE ACETAMINOPHEN TARGET ATTAINMENT AND HEPATOTOXICITY IN NON-PREGNANT AND PREGNANT WOMEN.

Mian, P.; van den Anker, J.; van Calsteren, K.; Annaert, P.; Tibboel, D.; Pfister, M.; Allegaert, K.; Dallmann, A.. Clinical Pharmacology and Therapeutics. 2019.

PREDICTION FETAL EXPOSURE TO ACETAMINOPHEN AND ITS METABOLITES USING PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING.

Mian, P.; Dallmann, A.; Conings, S.; Annaert, P.; Tibboel, D.; Pfister, M.; van Calsteren, K.; van den Anker, J.; Allegaert, K.. Clinical Pharmacology and Therapeutics. 2019.

Ultrafiltration rates in children on chronic hemodialysis routinely exceed weight based adult limit.

Gotta V; Pfister M; Marsenic O. Hemodialysis International. 2019.

Age- and weight-based differences in haemodialysis prescription and delivery in children, adolescents and young adults.

Gotta V; Marsenic O; Pfister M. Nephrology Dialysis Transplantation. 2018.

An advanced approach to compute the optimal dosing regimen with a PKPD model using optimal control theory

Bachmann, Freya; Pfister, Marc; Schropp, Johannes. Journal of Pharmacokinetics and Pharmacodynamics. 2018.

Apply machine learning methods to predict bilirubin progression and need for phototherapy in neonates

Vogt, Julia; Daunhawer, Imant; Koch, Gilbert; Kasser, Severin; Wellmann, Sven; Pfister, Marc. Journal of Pharmacokinetics and Pharmacodynamics. 2018.

Apply machine learning to predict the need for photherapy in neonates

Imant Daunhawer, Severin Kasser, Gilbert Koch, Marc Pfister, Sven Wellmann, Julia E. Vogt. . 2018.

Apply machine learning to predict the need for phototherapy in neonates

• Daunhawer I, Kasser S, Koch G, Pfister M, Wellmann S, Vogt . . 2018.

Bias between in vitro and in vivo mass-transfer coefficient of urea (KoA) is larger in pediatric than in adult patients on chronic hemodialysis.

• Verena Gotta, Olivera Marsenic, Marc Pfister. . 2018.

Characterization of postnatal sodium fluctuation in very preterm neonates

• Koch G, Corminboeuf F, Eugster N, Pfister M, Gerull R . . 2018.

Key Components for Antibiotic Dose Optimization of Sepsis in Neonates and Infants.

van Donge T; Bielicki JA; van den Anker J; Pfister M. Frontiers in Pediatrics. 2018.

Modelling of urea clearance in pediatric and young adult patients on chronic hemodialysis

• Verena Gotta, Olivera Marsenic, Marc Pfister. . 2018.

Neurofilament as Neuronal Injury Blood Marker in Preeclampsia.

Evers KS; Atkinson A; Barro C; Fisch U; Pfister M; Huhn EA; Lapaire O; Kuhle J; Wellmann S. Hypertension. 2018.

OptiDose: An advanced approach to compute optimal drug dosing schemes for a PKPD model using optimal control theory

• Bachmann F,; Pfister M,; Schropp J,; Koch G. . 2018.

Physiologically Based Pharmacokinetic Modeling in Pregnancy: A Systematic Review of Published Models.

Dallmann A; Pfister M; van den Anker J; Eissing T. Clinical Pharmacology and Therapeutics. 2018.

Quantitative Analysis of Gentamicin Exposure in Neonates and Infants Calls into Question Its Current Dosing Recommendations.

van Donge T; Pfister M; Bielicki J; Csajka C; Rodieux F; van den Anker J; Fuchs A. Antimicrobial Agents and Chemotherapy. 2018.

Release and Decay Kinetics of Copeptin vs AVP in Response to Osmotic Alterations in Healthy Volunteers.

Fenske WK; Schnyder I; Koch G; Walti C; Pfister M; Kopp P; Fassnacht M; Strauss K; Christ-Crain M. Journal of Clinical Endocrinology and Metabolism. 2018.

Ultrafiltration rates (UFR) observed in a large pediatric hemodialysis cohort routinely exceed weight based adult limit: call for action

• Verena Gotta, Olivera Marsenic, Marc Pfister. . 2018.

Caffeine Citrate Dosing Adjustments to Assure Stable Caffeine Concentrations in Preterm Neonates.

Koch G; Datta AN; Jost K; Schulzke SM; van den Anker J; Pfister M. Journal of Pediatrics. 2017.

CAFFEINE CITRATE DOSING ADJUSTMENT TO MAINTAIN TARGET CAFFEINE CONCENTRATION IN PRETERM NEONATES

Koch, G.; van den Anker, J.; Jost, K.; Datta, A.; Pfister, M.. Clinical Pharmacology and Therapeutics. 2017.

Characterization of body temperature, heart rate and sleeping patterns in preterm neonates

Koch, Gilbert; Pfister, Marc; Schulzke, Sven; Jost, Kerstin; Datta, Alexandre N.. Journal of Pharmacokinetics and Pharmacodynamics. 2017.

CHARACTERIZATION OF SLEEPING PATTERNS, BODY TEMPERATURE AND HEART RATES IN PRETERM NEONATES

Koch, G.; Pfister, M.; Schulzke, S.; Jost, K.; Datta, A. N.. SLEEP MEDICINE. 2017.

Characterizing the dynamic interaction among gastric emptying, glucose absorption, and glycemic control in nondiabetic obese adults.

Wilbaux M; Wölnerhanssen BK; Meyer-Gerspach AC; Beglinger C; Pfister M. American journal of physiology. Regulatory, integrative and comparative physiology. 2017.

Disease Progression Modeling to Evaluate the Effects of Enzyme Replacement Therapy on Kidney Function in Adult Patients with the Classic Phenotype of Fabry Disease.

Nowak A; Koch G; Huynh-Do U; Siegenthaler M; Marti HP; Pfister M. KIDNEY & BLOOD PRESSURE RESEARCH. 2017.

Exploratory Literature Meta-Analysis to Characterize the Relationship Between Early and Longer Term Body Weight Loss for Antiobesity Compounds.

Plock N; Bax L; Lee D; DeManno D; Lahu G; Pfister M. Journal of Clinical Pharmacology. 2017.

Facilitate Treatment Adjustment After Overdosing: Another Step Toward 21st-Century Medicine.

Koch G; Schropp J; Pfister M. Journal of Clinical Pharmacology. 2017.

GENTAMICIN EXPOSURE FOLLOWING VARIOUS DOSING REGIMENS ADMINISTERED IN NEONATES ACROSS SWISS NEONATAL INTENSIVE CARE UNITS AND INTERNATIONAL GUIDELINES

Tamara van Donge (1), Julia Bielicki (1,2), Andrew Atkinson (1,3), Johannes Van Den Anker (1,4,5), Frédérique Rodieux (6), Marc Pfister (1), Aline Fuchs (1). . 2017.

Guidance to develop individual dose recommendations for patients on chronic hemodialysis.

Gotta V; Dao K; Rodieux F; Buclin T; Livio F; Pfister M. Expert Review of Clinical Pharmacology. 2017.

Minimization of a utility function for optimizing the dosing frequency of amoxicillin administration in neonates according to a fixed PK/PD index Population Approach Group in Europe

Fuchs A, Bielicki J, Atkinson A, van den Anker JN, Pfister M.. . 2017.

Pharmacometric approaches to support dosing in neonates and infants with focus on antibiotics

Fuchs A & Wilbaux M, van Dongue T, Pfister M.. . 2017.

Pharmacometrics-based decision tools facilitate mHealth implementation.

Nekka F; Csajka C; Wilbaux M; Sanduja S; Li J; Pfister M. Expert Review of Clinical Pharmacology. 2017.

Validity of mobile electronic data capture in clinical studies: a pilot study in a pediatric population.

von Niederhäusern B; Saccilotto R; Schädelin S; Ziesenitz V; Benkert P; Decker ML; Hammann A; Bielicki J; Pfister M; Pauli-Magnus C. BMC Medical Research Methodology. 2017.

BODY-WEIGHT DEPENDENCY OF UREA KINETIC PARAMETERS IN ADOLESCENT HEMODIALYSIS PATIENTS

Gotta, Verena; Zhang, Liping; Couloures, Olivera Marsenic; Pfister, Marc. Nephrology Dialysis Transplantation. 2016.

Causes and Consequences of Variability in Drug Transporter Activity in Pediatric Drug Therapy.

Rodieux F; Gotta V; Pfister M; van den Anker JN. Journal of Clinical Pharmacology. 2016.

Characterizing and Forecasting Individual Weight Changes in Term Neonates.

Wilbaux M; Kasser S; Wellmann S; Lapaire O; van den Anker JN; Pfister M. Journal of Pediatrics. 2016.

Characterizing effects of carbimazole on free thyroxine levels in pediatric patients with Graves' disease

Morel, Catherine Ollagnier; Koch, Gilbert; Szinnai, Gabor; Pfister, Marc. Journal of Pharmacokinetics and Pharmacodynamics. 2016.

Characterizing the dynamic interaction among gastric emptying, glucose absorption and glycemic control in non-diabetic obese adults.

Wilbaux,Mélanie; Wölnerhanssen,Bettina K; Meyer-Gerspach,Anne Christin; Beglinger,Christoph; Pfister,Marc. American journal of physiology. Regulatory, integrative and comparative physiology. 2016.

COMPARISON OF BLOOD PRESSURE IN ADOLESCENT FORMER PRETERM INFANTS AND TERM CONTROLS

Staub, E.; Maurer, N.; Lemola, S.; Pfister, M.. European Journal of Pediatrics. 2016.

Effect of supplemental formula milk on physiological weight changes in neonates

Wilbaux, Melanie; Kasser, Severin; Coscia, Tania; Gromann, Julia; Mancino, Isabella; Wellmann, Sven; Pfister, Marc. Journal of Pharmacokinetics and Pharmacodynamics. 2016.

Pharmacometric Approaches to Personalize Use of Primarily Renally Eliminated Antibiotics in Preterm and Term Neonates.

Wilbaux M; Fuchs A; Samardzic J; Rodieux F; Csajka C; Allegaert K; van den Anker JN; Pfister M. Journal of Clinical Pharmacology. 2016.

Quantitative clinical pharmacology practice for optimal use of antibiotics during the neonatal period.

Samardzic J; Allegaert K; Wilbaux M; Pfister M; van den Anker JN. Expert opinion on drug metabolism & toxicology. 2016.

Simulations to simplify gentamicin dosing regimens for neonates and young infants when referral is not possible in developing countries Population Approach Group in Europe

Fuchs A, Gotta V, Van Den Anker JN, Pfister M. . 2016.

Therapeutic Drug Monitoring for Anti-infective Agents in Pediatrics: The Way Forward

Ritz N.; Bielicki J.; Pfister M.; Van Den Anker J.. Pediatric Infectious Disease Journal. 2016.

[Understanding and reducing the risk of adverse drug reactions in pediatric patients].

Gotta V; van den Anker J; Pfister M. Therapeutische Umschau. 2015.

Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children.

Rodieux F; Wilbaux M; van den Anker JN; Pfister M. Clinical Pharmacokinetics. 2015.

Enhancing Patient Flexibility of Subcutaneous Immunoglobulin G Dosing: Pharmacokinetic Outcomes of Various Maintenance and Loading Regimens in the Treatment of Primary Immunodeficiency.

Sidhu J; Rojavin M; Pfister M; Edelman J. Biologics in therapy. 2014.

Model-based exposure-response analysis of apixaban to quantify bleeding risk in special populations of subjects undergoing orthopedic surgery.

Leil TA; Frost C; Wang X; Pfister M; LaCreta F. CPT: pharmacometrics &amp; systems pharmacology. 2014.

Modeling and simulation for medical product development and evaluation: highlights from the FDA-C-Path-ISOP 2013 workshop.

Romero K; Sinha V; Allerheiligen S; Danhof M; Pinheiro J; Kruhlak N; Wang Y; Wang SJ; Sauer JM; Marier JF; Corrigan B; Rogers J; Lambers Heerspink HJ; Gumbo T; Vis P; Watkins P; Morrison T; Gillespie W; Gordon MF; Stephenson D; Hanna D; Pfister M; Lalonde R; Colatsky T. Journal of Pharmacokinetics and Pharmacodynamics. 2014.

Pharmacometrics in Chronic Kidney Disease

Zhang,Liping; Roy,Amit; Pfister,Marc. . 2014.

Subcutaneous immunoglobulin loading regimens for previously untreated patients with primary antibody deficiency.

Rojavin M; Sidhu J; Pfister M; Hubsch A. Clinical and Experimental Immunology. 2014.

A Nonlinear Mixed Effects Pharmacokinetic Model for Dapagliflozin and Dapagliflozin 3-O-glucuronide in Renal or Hepatic Impairment.

van der Walt JS; Hong Y; Zhang L; Pfister M; Boulton DW; Karlsson MO. CPT: pharmacometrics &amp; systems pharmacology. 2013.

Characterization of renal glucose reabsorption in response to dapagliflozin in healthy subjects and subjects with type 2 diabetes.

DeFronzo RA; Hompesch M; Kasichayanula S; Liu X; Hong Y; Pfister M; Morrow LA; Leslie BR; Boulton DW; Ching A; LaCreta FP; Griffen SC. Diabetes Care. 2013.

Pharmacokinetic modeling and simulation of biweekly subcutaneous immunoglobulin dosing in primary immunodeficiency.

Landersdorfer CB; Bexon M; Edelman J; Rojavin M; Kirkpatrick CM; Lu J; Pfister M; Sidhu J. POSTGRADUATE MEDICINE. 2013.

Pharmacometric Approaches to Guide Dose Selection of the Novel GPR40 Agonist TAK-875 in Subjects With Type 2 Diabetes Mellitus.

Naik H; Lu J; Cao C; Pfister M; Vakilynejad M; Leifke E. CPT: pharmacometrics &amp; systems pharmacology. 2013.

The influence of kidney function on dapagliflozin exposure, metabolism and pharmacodynamics in healthy subjects and in patients with type 2 diabetes mellitus.

Kasichayanula S; Liu X; Pe Benito M; Yao M; Pfister M; LaCreta FP; Humphreys WG; Boulton DW. British Journal of Clinical Pharmacology. 2013.

Affiliation between the American Society of Pharmacometrics and the Journal of Pharmacokinetics and Pharmacodynamics.

D'Argenio DZ; Gastonguay MR; Brundage RC; Miller R; Tannenbaum SJ; Pfister M. Journal of Pharmacokinetics and Pharmacodynamics. 2012.

A pharmacometric approach to quantify the impact of chronic kidney disease and hemodialysis on systemic drug exposure: application to saxagliptin.

Zhang L; Boulton DW; Pfister M. Journal of Clinical Pharmacology. 2012.

Design, Conduct, Analysis, and Interpretation of Clinical Studies in Patients With Impaired Kidney Function

Tortorici, Michael A.; Cutler, David; Zhang, Lei; Pfister, Marc. Journal of Clinical Pharmacology. 2012.

Novel dialysis modalities: do we need new metrics to optimize treatment?

Fissell R; Schulman G; Pfister M; Zhang L; Hung AM. Journal of Clinical Pharmacology. 2012.

Optimizing drug development and use in patients with kidney disease: opportunities, innovations, and challenges.

Pfister M; Nolin TD; Arya V. Journal of Clinical Pharmacology. 2012.

Time-varying belatacept exposure and its relationship to efficacy/safety responses in kidney-transplant recipients.

Zhou Z; Shen J; Hong Y; Kaul S; Pfister M; Roy A. Clinical Pharmacology and Therapeutics. 2012.